Total Funding
49
39
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
33537
Brinter is a U.S.-based medtech company pioneering 3D-bioprinted, bio-synthetic implants for orthopedic soft-tissue repair.
- Piira Marko: COO
- Tomi Kalpio: Inventor and co-founder
About the Company
Brinter is a U.S.-based medtech company pioneering 3D-bioprinted, bio-synthetic implants for orthopedic soft-tissue repair. Our core technology combines proprietary biomaterials with precision multi-material bioprinting, enabling implants engineered to mimic native biomechanical properties and promote regenerative healing. With a strong clinical
advisory network and R&D operations at Wake Forest Institute for Regenerative Medicine, in North Carolina. Brinter is advancing a new standard of care for tendon and ligament reconstruction — beginning with rotator cuff application. The company is targeting 510(k) Class II FDA clearance and commercial launch in Q1/2028.
